Fitness Wearables: Garmin, Whoop, Oura, Apple Watch Health — 2026-09-17
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Apple's launch of the Watch Series 12 and redesigned Health app has intensified competition with Oura and Whoop, introducing features like Readiness and Health Age. Meanwhile, new validation studies highlight significant accuracy differences in sleep staging between devices, and The Verge questions the scientific validity of "health age" metrics.
Fitness Wearables: Garmin, Whoop, Oura, Apple Watch Health — 2026-09-17
Top developments
Apple Watch Series 12 and Health App Redesign Target Subscription Rivals
On September 10, Apple introduced the Apple Watch Series 12 and a major redesign of the Health app for iOS 27, adding features previously exclusive to subscription-based competitors like Oura and Whoop. Key additions include a dedicated Readiness app, "Health Age," and denser Heart Rate Variability (HRV) tracking, all powered by the new Health Sensing System. This move directly challenges the value proposition of Whoop and Oura, which rely on monthly fees for similar readiness and recovery metrics, by bundling these insights into Apple's existing hardware ecosystem.
New Accuracy Study Ranks Wearable Sleep Staging Performance
A comprehensive breakdown of over 30 studies released this week ranks wearable accuracy across six major devices, revealing distinct strengths. WHOOP demonstrated the highest sensitivity for deep sleep detection at 69.6% in independent tests, while Apple Watch led in REM sleep detection at 68.6%. For nocturnal HRV and resting heart rate, the Oura Ring 4 achieved the highest correlation coefficients (0.99 and 0.98 respectively), reinforcing its position as a leader in physiological baseline tracking.
The Verge Critiques "Health Age" Metrics as Misleading
In a widely discussed column published on September 17, The Verge argued that the new "Health Age" feature, now available on Apple Watch and other platforms, is scientifically dubious and potentially misleading for users. The analysis suggests that while these metrics can offer motivational nudges, they lack the clinical rigor to be treated as reliable medical indicators, urging users to ignore them if they cause anxiety or confusion. This critique adds pressure on manufacturers to clarify the non-diagnostic nature of such derived metrics as they become mainstream features.
Garmin Adds New Colorways to vívoactive 6 in Japan
Garmin Japan announced the release of two new colorways for the vívoactive 6 smartwatch, French Gray/Paloma Cream Gold, available starting September 10, 2026. While not a hardware upgrade, this move signals Garmin's strategy to maintain market share in the wellness segment by refreshing aesthetics rather than pushing new sensor technology in its mid-range line, contrasting with Apple's aggressive feature expansion.
Local view
In Japan, Smart Watch Life reported on September 11 that HUAWEI, GARMIN, and Xiaomi remain top sellers on Yahoo! Shopping, with budget-friendly models under ¥10,000 gaining traction despite the premium health features launched by Apple. Japanese media outlets like Real Sound and ASCII highlighted the vívoactive 6 color updates, focusing on style over the new "Health Age" metrics dominating Western tech news, suggesting a regional preference for established wellness features like sleep coaching over experimental longevity scores.
Context & numbers
The shift in the wearables market is increasingly defined by subscription economics versus one-time hardware costs. A recent comparison by Memeburn highlights that Whoop and Oura are no longer just selling trackers but are positioning themselves as health service providers, with five-year costs significantly higher than Apple Watch due to mandatory subscriptions. Conversely, Apple's integration of Readiness and Health Age into the free Health app ecosystem removes the monthly fee barrier for millions of users, potentially disrupting the recurring revenue models of Whoop and Oura.
On the radar
- FDA Clearances: While Apple's hypertension notification feature received FDA clearance earlier in September, no new regulatory approvals were announced this week for other major players.
- Privacy Concerns: The EFF's July report on lack of transparency reports for wearables continues to influence consumer sentiment, with no new privacy policy updates from major brands this week.
- Upcoming Firmware: Garmin's Q3 2026 update cycle is ongoing, with users awaiting further details on Fenix 9 features, though the recent update focused on voice control and fall detection rather than new sensors.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
